Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions

AmyloidosisAmyloidAmyloid Neuropathies, FamilialAmyloid CardiomyopathyAmyloid - PrimaryTransthyretin AmyloidosisAL Amyloidosis

Trial Locations (1)

Cleveland Clinic, Cleveland

All Listed Sponsors

lead

The Cleveland Clinic

OTHER